Healthcare
Live Price
Offline$763.51
-0.04% today
1Y Change
+4.19%
Window
Jun 30, 2025 โ Jun 26, 2026
Coverage: 249 bars ยท Jun 30, 2025 โ Jun 26, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
McKesson Corporation (MCK) is a Healthcare stock with a market cap of $99.71B and listed on NYSE. The stock last traded around $763.51 and up 4.2% across the available one-year price window (Jun 30, 2025 โ Jun 26, 2026). Baseline metrics include revenue growth of +16.2%, EPS growth of +14.7%, a dividend yield of 0.4%. What stands out right now is revenue +16.2%, EPS +14.7%, free cash flow +44.1% with operating margin 1.3% and ROIC 24.0%. The dividend is present but secondary, with a yield around 0.4%. Valuation is more restrained than many high-expectation growth names at P/E 23.1 and price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines MCK price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
MCK is 13.79 pts behind over the shared 1Y window.
MCK had 18.04 pts deeper max drawdown than SPY.
MCK beat SPY in 1 of 2 calendar years shown and trailed in 1.
MCK
+4.19%
Normalized return
SPY
+17.99%
S&P 500
Excess Return
-13.79 pts
Relative to SPY
MCK Max Drawdown
-27.17%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for MCK and SPY.
| Year | MCK | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -7.28% | +6.71% | -13.98 pts | SPY |
| 2025 | +12.90% | +11.19% | +1.71 pts | MCK |
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.